| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -6.5e-05 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -4.6e-05 | 1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -4.9e-05 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 3.7e-05 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 2.1e-05 | 1 |